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Abstract
Purpose: To evaluate the effect of inactive form of platelet rich plasma (PRP) on the flap  via-
bility.
Methods: Thirty six rats were used. Rats were divided into six groups then 9x3 cm ran-
dom pattern skin flaps were elevated from dorsum of all rats. For precluding  vasculariza-
tion from the base, a silicone layer was placed under the flap in groups 2(only flap+silicone), 
4(saline+silicone) and 6(PRP+silicone). In groups 1(only flap), 2(only flap+silicone) nothing 
was done except  flap surgery. In  groups 3(saline) and  4(saline+silicone), saline was  applied 
intradermally , in groups 5(PRP) and  6(PRP+silicone), inactive form of  PRP which obtained 
from different 16 rats was  applied intradermally, into certain points of flaps immediately af-
ter surgery. After 7 days flap necrosis ratio  was measured in all groups.
Results: Mean necrosis rate in group 5(PRP) (16.05%) was statistically significantly lower 
than  group 1(only flap) (31,93%) and group 3(saline) (30,43%) (p<0.001). Mean necrosis 
rate in group 6(PRP+silicone) (36.37%) was statistically significantly lower than group 2(only 
flap+silicone) (47.93%) and group 4(saline+silicone) (45.65%) (p<0.001). 
Conclusion: Intradermal inactive platelet rich plasma administration decreases flap necrosis 
so for skin application.  
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becomes jelly and therefore it is not suitable 
for  injection by needle. Because of  this, 
special appartus should be used for application 
of PRP. Also, jelly form of PRP  is not suitable for 
administration into skin as well into skin flap, 
so  in previous  experimental study and  clinic 
use in cosmetic therapy, PRP was administered 
to subcutaneous level1,7. 
We hypothesized that activation of PRP is not 
necessary for protective effect of PRP on skin, 
and inactive form of PRP which is applied into 
the dermis would have viability increasing 
effect on flap. The objective of this study was 
to evaluate whether inactive form of  platelet-
rich plasma  would increase skin flap survival in 
an experimental rat model.
 ■ Methods
This study was performed in Gazi University, 
Faculty of Medicine, Laboratory Animals and 
Experimental Research Center after receiving 
the approval of Gazi University, Experimental 
Animals Ethics Committee. 
Fifty two Wistar-type female rats with weights 
between 200 and 300g, have been used in 
the study. PRP was obtained from 16 rats. The 
remaining 36 rats were kept in proper cages 
under conditions of 22 ± 20°C and 12 hours dark 
and 12 hours light. Nutrition requirements of 
the animals were addressed regularly by giving 
standard laboratory food and water.
All surgical procedures were performed with 
intraperitoneal administration of 50 mg/
kg ketamine-HCl (Alfamine®)  and  10 mg/
kg xylazine HCl (Rompun®) for  anesthesia by 
the same surgeon under sterilized conditions. 
After the surgical procedure, rats were kept in 
individual cages to preclude them from hurting 
each other. 
Preparation of Platelet-Rich Plasma (PRP)
The required blood for separation from other 
blood components of the platelet to form PRP 
 ■ Introduction
Random pattern skin flaps are commonly used 
for the reconstruction of defects in plastic 
surgery but despite the development of flap 
surgery techniques in recent years, partial or 
complete flap necrosis is still an important 
complication, especially in the distal region of 
the flap1. 
In the last 30 years, many studies have been 
performed to preclude necrosis and increase 
flap viability and many pharmacological 
agents such as, sympatholytics, vasodilators, 
prostaglandin inhibitors, anticoagulants, 
and free radical scavengers have been used 
experimentally in order to increase the viability 
of skin flaps2. However, a clinically useful 
treatment method hasn’t been developed yet 
in this regard3. 
Platelet-Rich Plasma (PRP) is a concentration 
in a small volume of plasma in platelets4. There 
are granules in platelets called alfa, beta and 
lambda  granules and alfa granules contains 
many growth factors including epidermal 
growth factor (EGF), fibroblast growth 
factor (FGF), insulin-like growth factor (IGF), 
keratinocyte growth factor (KGF), platelet-
derived growth factor (PDGF), transforming 
growth factor-beta (TGF-b) and vascular 
endothelial growth factor (VEGF)5. PRP, with 
its high-level growth factor contents, is used 
clinically for bone and wound healing, oral-
maxillofacial surgery, dental surgery and plastic 
surgery6,7.
Previously it was shown that PRP increase the 
viability of skin flaps in several experimental 
study1,8,9 and this effect of PRP is provided by 
growth factors in alfa granules. Degranulation 
of alfa granules is necessary for the secretion 
of growth factors from PRP and this is referred 
to as activation. In experimental study and also 
clinical application, PRP is activated by mixing 
with calcium(Ca) or thrombin5.  However,  by 
mixing  with calcium(Ca) or thrombin, PRP 
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was obtained by whole body blood collection 
from 16 donor rats with Ketamine HCl 
(Alfamine®-IM) and Xylazine HCl (Rompun®-IM) 
anesthesia through cardiac puncture.
270.000 platelet/liter were detected when 
platelet count was performed in 120 ml of 
blood obtained from the rats. Blood was 
placed into 3.8% sodium citrate containing 
tubes and centrifugation was performed. 
Tubes were centrifuged for 10 minutes at 
2400 rpm as described by Tobita et al.10. A 
thin layer (buffer coat) was placed between 
light yellow plasma supernatant and the red 
bottom layer. This middle layer and the upper 
plasma layer were transferred into different 
tubes. These tubes were centrifuged for a 
second time for 15 minutes at 3600 rpm. At the 
end of this procedure, platelet-poor plasma 
accumulated at the top. A total of 12 ml of 
platelet concentrate was taken into 1-cc insulin 
syringes to be used for the experiment. The 
platelet count was measured to be 931.000 
platelets/liters in the platelet concentrate 
prepared after centrifugation. Platelet count 
increased 3.5-fold.
Surgical procedure
All rats were anesthetized with intraperitoneal 
administration of 50 mg/kg ketamine-HCl 
(Alfamine®)  and  10 mg/kg xylazine HCl 
(Rompun®). Their backs were shaved, and the 
rats were fixed in a prone position. Surgical area 
was cleaned with 10% povidone iodine solution 
and covered under sterilized conditions. From 
their back, random patern dorsal flap included 
panniculus carnosus of 9 x 3 cm in size was 
elevated11. 3x4.5 cm silicone layer was placed 
under the distal region of the flap in 18 animals 
that were determined randomly for precluding 
vascularization from the wound bed. The other 
18 animals did not have any material under the 
flaps. Elevated flaps were sutured back with 
4/0 Vicryl. Surgical suture lines were cleaned 
with 10% povidone iodine solution.18 rats with 
silicone layers under the flap were divided into 
three groups with each group having 6 rats and 
named as groups 2, 4 and 6. The other 18 rats 
without silicone were again randomly divided 
into three groups with each group having 6 rats 
and the groups were named as 1, 3 and 5.
In group 1(only flap group) and group 2(only 
flap + silicone group) nothing was done except 
flap surgery . In group 3 (saline group) and 
group  4 (saline + silicone group)  immediately 
after surgery, a total of 0.9 cc saline was injected 
intradermally into specified points. In group 5 
(PRP  group) and group 6 (PRP + silicone group) 
immediately after surgery, a total of 0.9 cc pre-
prepared PRP was injected intradermally into 
specified points. PRP was injected inactivated 
form so PRP was not mixing with calcium(Ca) 
or thrombin for  activating.
PRP and saline were injected intradermally to 
nine points that were marked between  5 cm 
distal of pedicle to 7 cm distal of pedicle and 
0.5 cm medial of sides, to be 0.1 cc to each 
point.
After seven days of flap surgey,  all rats were 
euthanized with high dose of anesthesia (200 
mg/kg of pentobarbital). Photos of the flaps 
and necrosis areas on the backs of the rats 
were taken with Kodak Easy Share M320 digital 
camera from standard distance, and then 
computerized with Windows Picture Manger 
(Microsoft). Zones covered with scabs and dark 
zones were defined to be necrotic. By using 
digital analysis software (Photoshop CS; Adobe 
Systems, Inc., San Jose, Calif.) pixels of necrotic 
and and viable areas were counted  so necrotic 
and total flap area could be measured then 
the necrotic area percentages (necrotic area / 
all flap area x 100) were calculated.
Statistical analysis
Data analysis was performed in ‘SPSS for 
Windows 11.5’ package software. The 
normality of the distribution of continuous 
variables was evaluated with Shapiro-Wilk test 
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and homogeneity of the variances with Levene 
test.  Descriptive statistics were shown as 
mean ± standard deviation. Two-Way Analysis 
of Variance (Two-Way ANOVA) was used for 
statistical evaluation. In case main effects of 
intradermal injections types were found to be 
significant, ‘post hoc Tukey’ test was used to 
determine the cause of intergroup differences. 
Results were accepted to be statistically 
significant at a p<0.05  
 ■ Results
Mean necrosis ratio in groups are showed in 
Table 1, and Figures 1 and 2.
Table 1 - Mean necrosis ratio of groups.
Necrosis 
Ratio(%)
n Mean±SD
Group 1 
(only flap group)
6 31.93±3.28
Group 2  
(only flap + silicone 
group)
6 47.93±5.01
Group 3  
(saline group)
6 30.43±2.59
Group 4  
(saline + silicone 
group)
6 45.65±4.23
Group 5  
(PRP group)
6 16.05±3.98a,c,f
Group 6  
(PRP + silicone group)
6 36.37±2.94b,d,e
a
P<0.001 vs. group 1, 
b
P<0.001 vs. group 2, 
c
P<0.001 vs. group 
3, 
d
P<0.001 vs. group 4, 
e
P<0.001 vs. group 3, 
f
P<0.001 vs. 
group 4.
Figure 1 - Skin flap necrosis of the groups.
*Necrosis ratio in group 5 was statistically significantly lower 
than the group 1 (p<0,001)
#Necrosis ratio in group 5 was statistically significantly lower 
than the group 3 (p<0,001)
&Necrosis ratio in group 6 was statistically significantly lower 
than the group 2 (p<0,001)
σpNecrosis ratio in group 6 was statistically significantly lower 
than the group 4 (p<0,001)
ϵpNecrosis ratio in group 1 was statistically significantly lower 
than the group 2 (p<0,001)
ΦpNecrosis ratio in group 3 was statistically significantly lower 
than the group 4 (p<0,001)
χpNecrosis ratio in group 5 was statistically significantly lower 
than the group 6 (p<0,001)
Group 1 Group 2 Group 3 Group 4 Group 5 Group 6
Figure 2 - View of necrosis ratio of the flaps.
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Necrosis ratio in group 5 (PRP group) was 
statistically significantly lower than the group 
1(only flap group) and group 3(saline group) 
(p<0.001 and p<0.001, respectively), and 
there was no statistically significant difference 
in flap necrosis ratio between group 1(only 
flap group) and groups 3 (saline group). 
Necrosis ratio in group 6(PRP+silicone group) 
was statistically significantly lower than the 
group 2(only flap+silicone group) and group 
4(saline+silicone group) (p<0.001 and p<0.001, 
respectively), and there was no statistically 
significant difference in flap necrosis ratio 
between group 2 (only flap+silicone group)  and 
group 4(saline+silicone group). Necrosis ratio in 
group 5(PRP group) was statistically significantly 
lower than the group 6(PRP+silicone group) 
(p<0.001), necrosis ratio in group 3(saline 
group) was statistically significantly lower than 
the group 4(saline+silicone group)   (p<0.001) 
and necrosis ratio in group 1(only flap group) 
was statistically significantly lower than the 
group 2(only flap+silicone group) (p<0.001) 
(Table 1).
 ■ Discussion
Previously a few studies have been carried out 
on the effect of PRP on flap circulation. In these 
studies,  Findikcioglu et al.1 injected active form 
of PRP into subcutaneous layer of flap tissue 
one week before flap elevation, Li et al.8 and 
Wang et al.9 administered active form of  PRP 
into subcutaneous layer of flap tissue after 
flap elevation and all of that studies showed 
that active form of PRP increased flap viability. 
Unlike these studies, we applied inactive form 
of PRP into dermal layer of flap tissue and 
showed that  inactive form of PRP increased 
flap viability too.
In this study we used random patern dorsal 
skin flap model11 and we placed a silicone layer 
under the distal region of the flap in certain 
groups for inhibiting  revascularization from the 
wound  to demostrate flap viability increasing 
effect of inactive form of PRP is caused via 
revascularization from the wound  bed or not. 
In random pattern skin flap models as we used, 
52% part of the flap stays viable with basal 
vascularization as with composite graft12 so 
revascularization from the wound bed is very 
important for flap viability. In all of the previous 
studies about active form of PRP and flap 
viability, PRPprovided  flap viability  increasing 
effect by promoting  revascularization from the 
wound bed. In our study the least necrosis ratio 
was detected in the PRP group (group 5) but 
necrosis ratio in the PRP + silicone group (group 
6) was statistically significantly upper than only 
flap group (group 1) and salin group (group 3) 
so like subcutaneous application of PRP, dermal 
application of inactive form of PRP increase 
flap viability by providing  neovascularization 
from the wound bed. 
Previous studies about active form of PRP and 
flap viability, PRP was mixed  with thrombin, 
and calcium chloride for activation1,8,9. When 
PRP is activated, it become jelly form and that 
form isn’t suitable dermal injection so in all of 
that studies and clinical practices, PRP applied 
to subcutaneous layer. In our study we didn’t 
mix PRP with any solution for activation and we 
could injected that inactive form of PRP  to the 
dermal layer because of its liquid character. 
After flap elevation, plenty of ADP and AMP 
are formed due to ischemia13 and  also plenty 
of noradrenalin is present due to sympathetic 
discharge in flap tissues. These noradrenalin 
and ADP  cause degranulation of alfa granules 
and the secretion of growth factors from 
that granules14. Therefore, we believe that 
degranulation of alfa granules in inactively 
administered PRP was caused by noradrenalin 
and ADP in the dermis so flap necrosis ratio 
was decreased in our study. 
Using autologous PRP is technically impossible 
for small animals as they don’t have sufficient 
blood so we mixed blood obtained from 
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different 16 rats and prepared PRP from 
that blood15. During PRP separation with 
centrifugation as we did, leukocyte elimination 
from PRP content is not possible without 
using a cell separator so PRP contains a high 
concentration of leukocytes in addition to 
platelets4. In our study,  we didn’t do anything 
for leukocyte elimination from PRP  and by 
using PRP  obtained from different rats blood, 
we didn’t observed  any  adverse effect on flap 
circulation and any “graft versus host” reaction.
When groups with silicone placement under 
the flap (thereby precluding vascularization) 
were assessed (group 2, 4 and 6), the necrosis 
ratio in the flap was significantly lower in the 
group 6 (PRP + silicone group)  than other 
group 2(only flap+silicone) and group 4 (saline 
+ silicone group) and this shows that the flap 
viability increasing effect of PRP is caused not 
only via revascularization from the receiving 
bed. In the caudal based random pattern skin 
flap model11 that we used in this study, when 
the flap is elevated necrosis does not occur 
in the area close to the pedicle as there is 
adequate perfusion, and necrosis occurs in the 
ending area of the flap away from the pedicle 
due to ischemia. In the area called the transition 
zone between these areas, hyperadrenergic 
condition occurs due to noradrenalin released 
from the cut sympathetic nerves during flap 
elevation, and this causes an early ischemia 
but perfusion is restored within 12-24 hours 
when the hyperadrenergic condition ends16. 
Ischemia and the following reperfusion in 
this area cause ischemia-reperfusion injury 
(I-R)3 and in our study we think that PRP 
decreases I-R injury  on skin flap and by that 
way PRP decreases necrosis ratio in flap when 
vascularization preclude by putting silicone 
layer under the flap. 
 ■ Conclusion 
The intradermal inactive platelet rich plasma 
administration increases flap viability and 
decreases flap necrosis. 
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